V0R Stock Overview
A medtech company, offers electric endoscopic biopsy instruments for cancer diagnosis. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
BiBBInstruments AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.65 |
| 52 Week High | SEK 0.65 |
| 52 Week Low | SEK 0.17 |
| Beta | 1.06 |
| 11 Month Change | 0% |
| 3 Month Change | 38.30% |
| 1 Year Change | 130.50% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 85.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| V0R | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -0.4% | -0.4% |
| 1Y | 130.5% | -7.1% | 7.1% |
Return vs Industry: V0R exceeded the German Medical Equipment industry which returned 4.1% over the past year.
Return vs Market: V0R exceeded the German Market which returned 3.4% over the past year.
Price Volatility
| V0R volatility | |
|---|---|
| V0R Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: V0R's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine V0R's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 4 | Fredrik Lindblad | www.bibbinstruments.se |
BiBBInstruments AB, a medtech company, offers electric endoscopic biopsy instruments for cancer diagnosis. It is developing EndoDrill, an electric endoscopic biopsy instrument for endoscopic use. The company was incorporated in 2013 and is based in Lund, Sweden.
BiBBInstruments AB Fundamentals Summary
| V0R fundamental statistics | |
|---|---|
| Market cap | €12.72m |
| Earnings (TTM) | -€1.03m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-12.3x
P/E RatioIs V0R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| V0R income statement (TTM) | |
|---|---|
| Revenue | SEK 0 |
| Cost of Revenue | SEK 0 |
| Gross Profit | SEK 0 |
| Other Expenses | SEK 11.84m |
| Earnings | -SEK 11.83m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.41 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did V0R perform over the long term?
See historical performance and comparison